Healthbolt (Free subscription) | 06/12/2008
Former Charlies Angel Farrah Fawcett has been fighting a rare form of cancer since 2006 when she was diagnosed with anal cancer. According to the American Cancer Society, anal cancer is rare (an estimated 4,650 cases in 2006) but the number is rising, with those most affected being female and in their early 60’s. Farrah’s spent the [...]
Snarky Gossip (Free subscription) | 06/11/2008
Newscom Okay, so if you’re going to have cancer - especially anal cancer - you’re going to want to do it like Farrah Fawcett. She’s made literally millions of dollars giving exclusives to Entertainment Tonight, letting the show film her going through treatments and following her around. Neat, huh? Just for fun, I Googled anal cancer. [...]
PR-Inside.com Entertainment News (Free subscription) | 06/11/2008
FARRAH FAWCETT is negotiating a multi-million deal with major U.S. TV networks to broadcast a documentary about her battle with cancer. The 61-year-old actress, who last talked about her anal cancer ordeal on American show Entertainment Tonight earlier this year (08), has been followed around as she jets between the U.S. and Germany, where she is [...]
PR-Inside.com Entertainment News (Free subscription) | 06/02/2008
Actress FARRAH FAWCETT is "optimistic" she can beat anal cancer. The star was diagnosed with the disease in 2006, and has been jetting to Germany to be treated in a specialist clinic. Craig Nevius, who directed Fawcett, 61, in the new documentary about her battle, A Wing and a Prayer, reveals, "She is cautiously optimistic. [...]
A Blog Apart... (Free subscription) | 05/22/2008
People with HIV have a much higher risk for many cancers, including anal cancer, but a lower risk for prostate cancer, according to researchers.
MSNBC.com (Free subscription) | 05/21/2008
People with HIV have a much higher risk for many cancers, including anal cancer, but a lower risk for prostate cancer, researchers said on Tuesday.
Reuters UK (Free subscription) | 05/21/2008
WASHINGTON (Reuters) - People with HIV have a much higher risk for many cancers, including anal cancer, but a lower risk for prostate cancer, researchers said on Tuesday.
Reuters (Free subscription) | 05/21/2008
WASHINGTON (Reuters) - People with HIV have a much higher risk for many cancers, including anal cancer, but a lower risk for prostate cancer, researchers said on Tuesday.
Medical,Health News and Articles (Free subscription) | 04/23/2008
April 22 — Compared to the standard treatment regimen for anal canal cancer, the use of the chemotherapy drug cisplatin before other treatments didn't improve disease-free survival and resulted in a higher rate of colostomy procedures, says a U.S. study. Currently, the preferred primary therapy for patients with anal canal cancer is chemoradiation , which [...]
Medical News Today (Free subscription) | 04/23/2008
When administered before chemoradiation, the common anti-cancer drug cisplatin neither improved disease-free survival nor reduced the number of colostomies needed when compared to the standard treatment for patients with anal canal cancer, according to a study published in the April 23 issue of the Journal of the American Medical Association.
Medical,Health News and Articles (Free subscription) | 04/23/2008
Medical Studies/Trials When administered before chemoradiation, the common anti-cancer drug cisplatin neither improved disease-free survival nor reduced the number of colostomies needed when compared to the standard treatment for patients with anal canal cancer, according to [...]
Newswise (Free subscription) | 04/22/2008
When administered before chemoradiation, the common anti-cancer drug cisplatin neither improved disease-free survival nor reduced the number of colostomies needed when compared to the standard treatment for patients with anal canal cancer, according to a study published in the April 23 issue of the Journal of the American Medical Association.
Reuters (Free subscription) | 04/22/2008
CHICAGO (Reuters) - Treating anal cancer patients with the cancer-fighting drug cisplatin to try to shrink tumors before beginning standard therapy did not boost survival rates, and is not recommended, U.S. researchers said on Tuesday.
Reuters UK (Free subscription) | 04/22/2008
CHICAGO (Reuters) - Treating anal cancer patients with the cancer-fighting drug cisplatin to try to shrink tumors before beginning standard therapy did not boost survival rates, and is not recommended, U.S. researchers said on Tuesday.
Eurekalert (Free subscription) | 04/22/2008
When administered before chemoradiation, the common anti-cancer drug cisplatin neither improved disease-free survival nor reduced the number of colostomies needed when compared to the standard treatment for patients with anal canal cancer, according to a study published in the April 23 issue of the Journal of the American Medical Association.
